Back

Selective IgA2 deficiency in a patient with small intestinal Crohn's disease

Canales-Herrerias, P.; Garcia-Carmona, Y.; Meringer, H.; Martinez-Delgado, G.; Tankelevich, M.; Colombel, J.-F.; Cunningham-Rundles, C.; Cerutti, A.; Mehandru, S.

2022-12-07 gastroenterology
10.1101/2022.12.03.22282315 medRxiv
Show abstract

The human IgA response is composed of two structurally different subclasses termed IgA1 and IgA2. Compared to IgA1, IgA2 has a shorter hinge region, which makes it more resistant to bacterial proteases. IgA1 is produced both systemically and in mucosal surfaces, whereas IgA2 is mostly confined to the intestines. While the overall IgA response is known to be involved in intestinal homeostasis, the specific contribution of IgA1 and IgA2 remains largely unknown (Chen 2020). Selective IgA deficiency (SIgAD) is the most prevalent primary immune deficiency. About half of SIgAD cases are associated with heterogeneous but generally mild clinical manifestations. Anecdotal evidence of IgA2 deficiency is available (van Loghem 1983, Ozawa 1986, Engstrom 1990), however no associations with clinical manifestations have been reported. Here, we describe the occurrence of a selective IgA2 deficiency in a patient (CD068) with small intestinal Crohns disease (CD). The patient had undetectable IgA2+ cells and secreted IgA2 antibody in both intestine and circulation. Among other features, patient CD068 presented with duodenal and ileal inflammation. To our knowledge, this is the first case of IgA2 deficiency with a potential link to IBD, which might shed new insights into potential IgA2-specific functions.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Inflammatory Bowel Diseases
16 papers in training set
Top 0.1%
46.6%
2
Journal of Crohn's and Colitis
11 papers in training set
Top 0.1%
8.0%
50% of probability mass above
3
Gastroenterology
42 papers in training set
Top 0.4%
2.7%
4
Gastro Hep Advances
11 papers in training set
Top 0.1%
2.5%
5
Gut
40 papers in training set
Top 0.4%
2.5%
6
eLife
5828 papers in training set
Top 40%
2.4%
7
EMBO Molecular Medicine
95 papers in training set
Top 0.7%
2.0%
8
Gut Microbes
78 papers in training set
Top 0.8%
1.9%
9
iScience
1154 papers in training set
Top 14%
1.9%
10
PLOS ONE
5266 papers in training set
Top 47%
1.8%
11
JCI Insight
277 papers in training set
Top 4%
1.8%
12
Clinical and Experimental Immunology
12 papers in training set
Top 0.1%
1.5%
13
mBio
833 papers in training set
Top 8%
1.5%
14
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.7%
1.1%
15
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 2%
1.1%
16
Cancer Immunology, Immunotherapy
12 papers in training set
Top 0.1%
1.1%
17
Journal of Experimental Medicine
119 papers in training set
Top 2%
1.1%
18
Cell Reports Medicine
153 papers in training set
Top 4%
1.1%
19
Frontiers in Immunology
638 papers in training set
Top 8%
1.0%
20
Frontiers in Pharmacology
111 papers in training set
Top 3%
0.9%
21
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
0.9%
22
Scientific Reports
3612 papers in training set
Top 73%
0.9%
23
PLOS Pathogens
820 papers in training set
Top 9%
0.9%
24
Science Translational Medicine
127 papers in training set
Top 4%
0.6%
25
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 5%
0.6%
26
Immunity
67 papers in training set
Top 2%
0.6%
27
Nature Medicine
125 papers in training set
Top 4%
0.6%